Rosiglitazone promotes ENaC-mediated alveolar fluid clearance in acute lung injury through the PPARγ/SGK1 signaling pathway

Lignende værker

• Regulation of ENaC-mediated alveolar fluid clearance by insulin via PI3K/Akt pathway in LPS-induced acute lung injury
  af: Deng, Wang, et al.
  Udgivet: (2012)
• ENaC-mediated alveolar fluid clearance and lung fluid balance depend on the channel-activating protease 1
  af: Planès, Carole, et al.
  Udgivet: (2010)
• PPARγ agonist-induced fluid retention depends on αENaC expression in connecting tubules
  af: Fu, Yiling, et al.
  Udgivet: (2014)
• Fluid Retention Caused by Rosiglitazone Is Related to Increases in AQP2 and αENaC Membrane Expression
  af: Jinghua Xu, et al.
  Udgivet: (2017-01-01)
• Fluid Retention Caused by Rosiglitazone Is Related to Increases in AQP2 and αENaC Membrane Expression
  af: Xu, Jinghua, et al.
  Udgivet: (2017)